Amgen (AMGN) Growth In Brazil Picks Up, Eyes Doubling Portfolio By 2020
7/24/2014 6:02:42 AM
Amgen Inc, the world's biggest biotechnology company, has had a surge in sales in Brazil this year and it plans to double its drug portfolio in the country by the end of the decade, the company's top local executive says. Eduardo Santos, head of Amgen Brasil, said in a recent interview that revenue rose 54 percent from a year earlier in the first half of 2014, more than double the company's average annual growth in Brazil since it arrived three years ago.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by